Showing results (31-40 of 56) with videos related to

Sort By:
Pageof 6
The Journal of Allergy and Clinical Immunology|August 16, 2020
Early epitope-specific IgE antibodies are predictive of childhood peanut allergyMaria Suprun, Scott H Sicherer, Robert A Wood, et al.
Addiction (Abingdon, England)|January 7, 2017
Feasibility and safety of extended-release naltrexone treatment of opioid and alcohol use disorder in HIV clinics: a pilot/feasibility randomized trialPhilip T Korthuis, Paula J Lum, Pamela Vergara-Rodriguez, et al.
The Journal of Allergy and Clinical Immunology|May 11, 2010
Immunologic features of infants with milk or egg allergy enrolled in an observational study (Consortium of Food Allergy Research) of food allergyScott H Sicherer, Robert A Wood, Donald Stablein, et al.
Plos One|October 22, 2016
Loss to Follow-Up from HIV Screening to ART Initiation in Rural ChinaDiane Gu, Yurong Mao, Zhenzhu Tang, et al.
JAMA Internal Medicine|September 3, 2014
Brief intervention for patients with problematic drug use presenting in emergency departments: a randomized clinical trialMichael P Bogenschutz, Dennis M Donovan, Raul N Mandler, et al.
The Journal of Allergy and Clinical Immunology|February 7, 2015
Sublingual immunotherapy for peanut allergy: Long-term follow-up of a randomized multicenter trialA Wesley Burks, Robert A Wood, Stacie M Jones, et al.
Contemporary Clinical Trials|August 14, 2016
NIDA Clinical Trials Network CTN-0051, Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment (X:BOT): Study design and rationaleJoshua D Lee, Edward V Nunes, Patricia Novo Mpa, et al.
The Journal of Allergy and Clinical Immunology|December 26, 2012
Sublingual immunotherapy for peanut allergy: a randomized, double-blind, placebo-controlled multicenter trialDavid M Fleischer, A Wesley Burks, Brian P Vickery, et al.
Pageof 6